HCPCS code lookup
HCPCS Level II
Q2056
Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Ask Rivvi
- Code
- Q2056
- Description
- Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
NDC crosswalk
- 57894-0111-01 Carvykti, Janssen Biotech, Inc.. Billable units per 11-digit NDC: 1.
- 57894-0111-02 Carvykti, Janssen Biotech, Inc.. Billable units per 11-digit NDC: 1.
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.